Should I Buy SRXH? SRXH 2026 Analysis

Should You Buy Srx Health Solutions Inc (SRXH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.150

1 Day change

-2.59%

52 Week Range

2.020

Analysis Updated At

2026/01/26

SRx Health Solutions Inc (SRXH) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company is experiencing financial struggles, with no revenue in the latest quarter, a significant decline in stock value over the past year, and bearish technical indicators. Additionally, there are no strong positive catalysts or trading signals to suggest immediate upside potential.

Technical Analysis

The technical indicators are bearish. The MACD histogram is negative and contracting, RSI is neutral at 24.253, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 0.156), with resistance levels at R1: 0.21 and R2: 0.227.

Options Data

Positive Catalysts

2026/01/26 05:38:01

SRx Health has announced an investment in Opendoor Technologies, which could enhance market competitiveness. Additionally, the company is preparing for a merger with EMJ Crypto Technologies, which may provide future growth opportunities.

Neutral/Negative Catalysts

2026/01/26 05:38:01

The stock has declined 91% over the past year. Financial performance is poor, with revenue dropping to 0 in Q4 2025 and gross margin declining by 35.82%. Retail sentiment remains neutral, and there is no clear decision on a reverse stock split, which adds uncertainty.

Financial Performance

In Q4 2025, revenue dropped to 0 (-100% YoY), net income increased to -$15,261,000 (+906% YoY), EPS dropped to -0.58 (-38.3% YoY), and gross margin fell to 23.35% (-35.82% YoY). The company is struggling financially with no clear growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

There is no specific analyst rating data provided. However, the stock's poor performance and lack of significant trading trends suggest a lack of strong positive sentiment from analysts or institutional investors.

Analyst Rating

Wall Street analysts forecast SRXH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRXH is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 0.155

Low

Averages

High